Mesenchymal Stem Cells and Induced Bone Marrow‐Derived Macrophages Synergistically Improve Liver Fibrosis in Mice

MLA

Watanabe, Yusuke, et al. “Mesenchymal Stem Cells and Induced Bone Marrow‐Derived Macrophages Synergistically Improve Liver Fibrosis in Mice.” Stem Cells Translational Medicine, vol. 8, no. 3, Mar. 2019, pp. 271–84. EBSCOhost, https://doi.org/10.1002/sctm.18-0105.

APA

Watanabe, Y., Tsuchiya, A., Seino, S., Kawata, Y., Kojima, Y., Ikarashi, S., Starkey Lewis, P. J., Lu, W., Kikuta, J., Kawai, H., Yamagiwa, S., Forbes, S. J., Ishii, M., & Terai, S. (2019). Mesenchymal Stem Cells and Induced Bone Marrow‐Derived Macrophages Synergistically Improve Liver Fibrosis in Mice. Stem Cells Translational Medicine, 8(3), 271–284. https://doi.org/10.1002/sctm.18-0105

Chicago

Watanabe, Yusuke, Atsunori Tsuchiya, Satoshi Seino, Yuzo Kawata, Yuichi Kojima, Shunzo Ikarashi, Philip J. Starkey Lewis, et al. 2019. “Mesenchymal Stem Cells and Induced Bone Marrow‐Derived Macrophages Synergistically Improve Liver Fibrosis in Mice.” Stem Cells Translational Medicine 8 (3): 271–84. doi:10.1002/sctm.18-0105.